Organoids Increase the Predictive Value of in vitro Cancer Chemoprevention Studies for in vivo Outcome by Rose N. Njoroge, Rose N. Njoroge, Rajita J. Vatapalli, Rajita J. Vatapalli, Sarki A. Abdulkadir, Sarki A. Abdulkadir, Sarki A. Abdulkadir

Get full text

Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity by Roh Meejeon, Kim Jongchan, Abdulkadir Sarki A

Get full text

Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice. by Erin E Martinez, Philip D Anderson, Monica Logan, Sarki A Abdulkadir

Get full text

Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer. by Jongchan Kim, Isam-Eldin A Eltoum, Meejeon Roh, Jie Wang, Sarki A Abdulkadir

Get full text

A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. by Meejeon Roh, Omar E Franco, Simon W Hayward, Riet van der Meer, Sarki A Abdulkadir

Get full text

Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy by Jonathan F. Anker, Anum F. Naseem, Hanlin Mok, Anthony J. Schaeffer, Sarki A. Abdulkadir, Praveen Thumbikat

Get full text

Mental health interventions for adolescents in sub-Saharan Africa: a scoping review by Mabrouk, A, Mbithi, G, Chongwo, E, Too, E, Sarki, A, Namuguzi, M, Atukwatse, J, Ssewanyana, D, Abubakar, A

Mental health and psychological well-being of Kenyan adolescents from Nairobi and the Coast regions in the context of COVID-19 by Mbithi, G, Mabrouk, A, Sarki, A, Odhiambo, R, Namuguzi, M, Dzombo, JT, Atukwatse, J, Kabue, M, Mwangi, P, Abubakar, A

Prostate Stroma Increases the Viability and Maintains the Branching Phenotype of Human Prostate Organoids by Zachary Richards, Tara McCray, Joseph Marsili, Morgan L. Zenner, Jacob T. Manlucu, Jason Garcia, Andre Kajdacsy-Balla, Marcus Murray, Cindy Voisine, Adam B. Murphy, Sarki A. Abdulkadir, Gail S. Prins, Larisa Nonn

Get full text

Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC by Sukanya Panja, Mihai Ioan Truica, Christina Y. Yu, Vamshi Saggurthi, Michael W. Craige, Katie Whitehead, Mayra V. Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan, Suril Gohel, Frederick Coffman, James S. Parrott, Songhua Quan, Shantenu Jha, Isaac Kim, Edward Schaeffer, Vishal Kothari, Sarki A. Abdulkadir, Antonina Mitrofanova

Get full text